Better use of EMA support tools and increased success rate for SME applications
Micro-, small- and medium-sized enterprises (SMEs) are making better use of the various regulatory tools that the European Medicines Agency’s (EMA) has put in place to support them during the development of their medicines. In addition, between 2011 and 2014, 62% of SME applications for marketing authorisation were granted a positive opinion by EMA’s Committee for Medicinal Products… Read More »